108 related articles for article (PubMed ID: 533991)
21. [Changes in the effect of some antineoplastic agents after erythropoietic stimulation].
Bogliolo G; Saviane A; Massa G; Ghio R; Bianchi G; Pannacciulli I
Tumori; 1976; 62(4):445-54. PubMed ID: 1020051
[No Abstract] [Full Text] [Related]
22. [The toxic action of antineoplastic chemotherapeutic agents evaluated by study of hemopoietic stem cells].
Pannacciulli I; Ghio R; Bianchi G; Bogliolo G; Saviane A; Massa G
Minerva Med; 1978 Dec; 69(61):4257-65. PubMed ID: 366466
[No Abstract] [Full Text] [Related]
23. [Disorders of bone marrow hematopoiesis long time after the action of cytostatic preparations].
Bogdashin IV; Sycheva EV; Zhdanov VV; Afanas'eva ON; Zapuskalova OP; Novitskiĭ VV; Gol'dberg ED
Biull Eksp Biol Med; 1992 Mar; 113(3):283-4. PubMed ID: 1421227
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration.
Lucas D; Scheiermann C; Chow A; Kunisaki Y; Bruns I; Barrick C; Tessarollo L; Frenette PS
Nat Med; 2013 Jun; 19(6):695-703. PubMed ID: 23644514
[TBL] [Abstract][Full Text] [Related]
25. Effects of the mode of administration of mitomycin on tumor and marrow response and on the therapeutic ratio.
Rockwell S; Nierenburg M; Irvin CG
Cancer Treat Rep; 1987 Oct; 71(10):927-34. PubMed ID: 3652056
[TBL] [Abstract][Full Text] [Related]
26. Circadian and seasonal rhythms in murine bone marrow colony-forming cells affect tolerance for the anticancer agent 4'-O-tetrahydropyranyladriamycin (THP).
Lévi F; Blazsek I; Ferlé-Vidovic A
Exp Hematol; 1988 Sep; 16(8):696-701. PubMed ID: 3402557
[TBL] [Abstract][Full Text] [Related]
27. Cancer chemotherapy. I.
Greenwald ES
N Y State J Med; 1972 Oct; 72(20):2541-56. PubMed ID: 4627868
[No Abstract] [Full Text] [Related]
28. Sensitivity of human and murine hemopoietic precursor cells to chemotherapeutic agents assessed in cell culture.
Ogawa M; Bergsagel DE; McCulloch EA
Blood; 1973 Dec; 42(6):851-6. PubMed ID: 4759912
[No Abstract] [Full Text] [Related]
29. [Reactivity of the blood system in the late periods following administration of the antitumor antibiotic rubomycin].
Novitskiĭ VV; Fursov SE; Gol'dberg ED
Biull Eksp Biol Med; 1985 Dec; 100(12):718-9. PubMed ID: 4074877
[TBL] [Abstract][Full Text] [Related]
30. On the neurotoxic effects induced by alkylating agents.
Donelli MG; Rosso R; Garattini S
J Pharm Pharmacol; 1966 Nov; 18(11):760-2. PubMed ID: 4382059
[No Abstract] [Full Text] [Related]
31. It takes nerves to recover from chemotherapy.
Levesque JP; Winkler IG
Nat Med; 2013 Jun; 19(6):669-71. PubMed ID: 23744143
[No Abstract] [Full Text] [Related]
32. Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration.
Molyneux G; Andrews M; Sones W; York M; Barnett A; Quirk E; Yeung W; Turton J
Cell Biol Toxicol; 2011 Feb; 27(1):13-40. PubMed ID: 20589437
[TBL] [Abstract][Full Text] [Related]
33. Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
Gulati SC; Atzpodien J; Langleben A; Shimazaki C; Jain K; Yopp J; Ng RP; Colvin OM; Clarkson BD
Acta Haematol; 1988; 80(2):65-70. PubMed ID: 2458665
[TBL] [Abstract][Full Text] [Related]
34. Medroxyprogesterone acetate does not protect human bone marrow progenitor cells exposed to adriamycin in vitro.
Umbach GE; Spitzer G; Drewinko B; Gercovich G; Hortobagyi G
Breast Cancer Res Treat; 1985; 5(1):87-9. PubMed ID: 3156645
[No Abstract] [Full Text] [Related]
35. The effect of N-acetylcysteine on toxicity of cyclophosphamide and doxorubicin on murine hemopoietic progenitors.
Massa G; Muzzulini C; Bogliolo G; Pannacciulli I
Life Sci; 1985 Mar; 36(12):1141-7. PubMed ID: 3982211
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-fluorouracil on mouse bone marrow.
Radley JM; Scurfield G
Br J Haematol; 1979 Nov; 43(3):341-51. PubMed ID: 497116
[TBL] [Abstract][Full Text] [Related]
37. Acute and chronic dose/response effects of inhaled benzene on multipotential hematopoietic stem (CFU-S) and granulocyte/macrophage progenitor (GM-CFU-C) cells in CD-1 mice.
Green JD; Snyder CA; LoBue J; Goldstein BD; Albert RE
Toxicol Appl Pharmacol; 1981 May; 58(3):492-503. PubMed ID: 7245216
[No Abstract] [Full Text] [Related]
38. Suitability of a new stable acetal analogue of aldoifosphamide for purging leukemic cells from human bone marrow.
Andersson BS; Wang YQ; McCredie KB; Farquhar D
Leukemia; 1990 Jun; 4(6):435-40. PubMed ID: 2359343
[TBL] [Abstract][Full Text] [Related]
39. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
[TBL] [Abstract][Full Text] [Related]
40. The A.H.E.A.D. method: a quantitative automated measurement of the hematotoxicity of anticancer drugs.
Saint-Dizier D; Sancier M; Cudennec CA
Anticancer Res; 1990; 10(3):765-71. PubMed ID: 2369090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
